Concepedia

Publication | Open Access

Risk of COVID-19 in Patients with Cancer Receiving Immune Checkpoint Inhibitors

DOIFull Paper Access

12

Citations

7

References

2021

Year

Nikolai Klebanov, Vartan Pahalyants, William S. Murphy, Nicholas Theodosakis, Leyre Zubiri, R. Monina Klevens, Shawn G. Kwatra, Evelyn Lilly, Kerry L. Reynolds, Yevgeniy R. Semenov
The Oncologist

Abstract

ICIs did not increase the rate of COVID-19. This information may assist patients and their oncologists in decision-making surrounding cancer treatment during this pandemic.

References

YearCitations

Page 1